Editorial of the Special Issue "Targeted Therapies for Cancer"
Editorial of the Special Issue "Targeted Therapies for Cancer"
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
[...]Tamoxifen, which specifically targets the estrogen receptor in breast cancer, is the first drug approved by the Food and Drug administration (FDA) in 1977 as cellular targeted therapy for the treatment of metastatic breast-cancer-affected patients [1] and continues to be one of the most widely used treatment options. [...]the identification of...
Alternative Titles
Full title
Editorial of the Special Issue "Targeted Therapies for Cancer"
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2fa279ba5e5140b38ac10e1f856289d3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2fa279ba5e5140b38ac10e1f856289d3
Other Identifiers
ISSN
2227-9059
E-ISSN
2227-9059
DOI
10.3390/biomedicines10051114
